Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Marja P. Van Dieijen"'
Autor:
Dorien M. Kimenai, Remy J. H. Martens, Jeroen P. Kooman, Coen D. A. Stehouwer, Frans E. S. Tan, Nicolaas C. Schaper, Pieter C. Dagnelie, Miranda T. Schram, Carla J. H. van der Kallen, Simone J. S. Sep, Jeroen D. E. van Suijlen, Abraham A. Kroon, Otto Bekers, Marja P. van Dieijen-Visser, Ronald M. A. Henry, Steven J. R. Meex
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Abstract Interest in high-sensitivity cardiac troponin I(hs-cTnI) and T(hs-cTnT) has expanded from acute cardiac care to cardiovascular disease(CVD) risk stratification. Whether hs-cTnI and hs-cTnT are interchangeable in the ambulant setting is large
Externí odkaz:
https://doaj.org/article/8b30408b346c4d62ab48664acb2cf641
Autor:
Alexander S. Streng, Douwe de Boer, Freek G. Bouwman, Edwin C.M. Mariman, Arjen Scholten, Marja P. van Dieijen-Visser, Will K.W.H. Wodzig
Publikováno v:
Data in Brief, Vol 7, Iss , Pp 397-405 (2016)
Cardiac troponin T (cTnT) fragmentation in human serum was investigated using a newly developed targeted selected ion monitoring assay, as described in the accompanying article: “Development of a targeted selected ion monitoring assay for the eluci
Externí odkaz:
https://doaj.org/article/d5d095d3522e4e3ea38d0cb94fade487
Autor:
Eline P M Cardinaels, Sibel Altintas, Mathijs O Versteylen, Ivo A Joosen, Laurens-Jan C Jellema, Joachim E Wildberger, Marco Das, Harry J Crijns, Otto Bekers, Marja P van Dieijen-Visser, Bastiaan L Kietselaer, Alma M A Mingels
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0153300 (2016)
BACKGROUND:High-sensitivity cardiac troponins (hs-cTn) are the preferred biomarkers to detect myocardial injury, making them promising risk-stratifying tools for patients with symptoms of chest pain. However, circulating hs-cTn are also elevated in o
Externí odkaz:
https://doaj.org/article/2624776d419746e1af6db13e52208f00
Autor:
Frans E. S. Tan, Ronald M.A. Henry, Simone J. S. Sep, Jeroen P. Kooman, Remy J.H. Martens, Frank M. van der Sande, Otto Bekers, Marja P. van Dieijen-Visser, Pieter C. Dagnelie, Karel M.L. Leunissen, Coen D.A. Stehouwer, Carla J.H. van der Kallen, Jeroen D.E. van Suijlen, Dorien M Kimenai, Nicolaas C. Schaper, Miranda T. Schram, Abraham A. Kroon, Steven J.R. Meex
Publikováno v:
Clinical Chemistry, 63(4), 887-897. American Association for Clinical Chemistry
BACKGROUNDChronic kidney disease (CKD) is associated with an increased cardiovascular disease mortality risk. It is, however, less clear at what point in the course from normal kidney function to CKD the association with cardiovascular disease appear
Autor:
Douwe de Boer, William P. T. M. van Doorn, Marja P. van Dieijen-Visser, Edwin C. M. Mariman, Alexander S. Streng, Freek G. Bouwman, Will K. W. H. Wodzig, Otto Bekers
Publikováno v:
Clinical Chemistry, 63(2), 563-572. American Association for Clinical Chemistry
BACKGROUNDCardiac troponin T (cTnT) is the preferred biomarker for the diagnosis of acute myocardial infarction (AMI). It has been suggested that cTnT is present predominantly in fragmented forms in human serum following AMI. In this study, we have u
Autor:
Jasper R. Vermeer, Sebastiaan C.A.M. Bekkers, Pieter C. Dagnelie, Alma M.A. Mingels, Joachim E. Wildberger, Juliette Vervuurt, Bas L.J.H. Kietselaer, Martijn W. Smulders, Hans-Peter Brunner-La Rocca, Anna Liefhebber, Yvonne J. M. van Cauteren, Harry J.G.M. Crijns, Marja P. van Dieijen-Visser
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 9, p e0203506 (2018)
PLOS ONE, 13(9):e0203506. Public Library of Science
PLoS ONE, Vol 13, Iss 9, p e0203506 (2018)
PLOS ONE, 13(9):e0203506. Public Library of Science
Background Normal high sensitivity cardiac troponin (hs-cTn) assays rule out acute myocardial infarction (AMI) with great accuracy, but additional non-invasive testing is frequently ordered. This observational study evaluates whether clinical charact
Autor:
Kristin M. Aakre, Fred S. Apple, Angelika Hammerer-Lercher, Sanja Stankovic, Michel Langlois, Robert H. Christenson, Hannsjoerg Baum, Marja P. van Dieijen-Visser, Ana Stavljenić-Rukavina, Christopher J. Duff, Päivi Laitinen, Kari Pulkki, Paul O. Collinson, Janne Suvisaari
Publikováno v:
Clinical Chemistry, 62(9), 1264-1271. American Association for Clinical Chemistry
BACKGROUND We undertook an assessment of current use of evidence-based guidelines for the use of cardiac biomarkers in Europe (EU) and North America (NA). METHODS In 2013–2014 a web-based questionnaire was distributed via NA and EU biochemical soci
Autor:
Freek G. Bouwman, Douwe de Boer, Edwin C. M. Mariman, Marja P. van Dieijen-Visser, Arjen Scholten, Will K. W. H. Wodzig, Alexander S. Streng
Publikováno v:
Data in brief, 7, 397-405. Elsevier Science
Data in Brief, Vol 7, Iss, Pp 397-405 (2016)
Data in Brief
Data in Brief, Vol 7, Iss, Pp 397-405 (2016)
Data in Brief
Cardiac troponin T (cTnT) fragmentation in human serum was investigated using a newly developed targeted selected ion monitoring assay, as described in the accompanying article: "Development of a targeted selected ion monitoring assay for the elucida
Autor:
Miranda T. Schram, Steven J.R. Meex, Otto Bekers, Carla J.H. van der Kallen, Dorien M Kimenai, Jeroen D.E. van Suijlen, Marja P. van Dieijen-Visser, Ronald M.A. Henry, Coen D.A. Stehouwer, Nicolaas C. Schaper, Marijke Niens, Pieter C. Dagnelie, Simone J. S. Sep
Publikováno v:
Heart, 102(8), 610-616. BMJ Publishing Group
Objective The 99th percentile upper reference limit of high-sensitivity cardiac troponin (hs-cTn) from a healthy reference population is used for diagnosing acute myocardial infarction (AMI). Accepted current thresholds of hs-cTnT (Roche) and hs-cTnI
Autor:
Will K. W. H. Wodzig, Freek G. Bouwman, Edwin C. M. Mariman, Alexander S. Streng, Marja P. van Dieijen-Visser, Douwe de Boer, Arjen Scholten
Publikováno v:
Journal of Proteomics, 136, 123-132. Elsevier Science
Cardiac troponin T (cTnT) is a highly cardiospecific protein commonly used in the diagnosis of acute myocardial infarction (AMI), but is subject to proteolytic degradation upon its release in the circulation. In this study, a targeted mass spectromet